NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 201 filers reported holding NEVRO CORP in Q1 2022. The put-call ratio across all filers is 1.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $254,000 | -30.4% | 3,137 | 0.0% | 0.07% | -50.7% |
| Q3 2021 | $365,000 | -29.8% | 3,137 | 0.0% | 0.14% | +6.8% |
| Q2 2021 | $520,000 | +18.7% | 3,137 | 0.0% | 0.13% | +47.8% |
| Q1 2021 | $438,000 | -98.9% | 3,137 | -98.7% | 0.09% | -98.9% |
| Q4 2020 | $41,392,000 | +104.7% | 239,122 | +64.7% | 8.25% | +67.4% |
| Q3 2020 | $20,220,000 | -12.2% | 145,153 | -24.7% | 4.93% | -9.8% |
| Q2 2020 | $23,028,000 | -17.6% | 192,754 | -19.0% | 5.46% | +10.1% |
| Q4 2019 | $27,961,000 | +29.5% | 237,883 | -5.3% | 4.96% | -12.5% |
| Q3 2019 | $21,589,000 | +106.4% | 251,127 | +55.7% | 5.67% | +160.2% |
| Q2 2019 | $10,458,000 | – | 161,321 | – | 2.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |